SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001159036-17-000038
Filing Date
2017-08-08
Accepted
2017-08-08 16:13:22
Documents
65
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q halo2q2017-10q.htm 10-Q 1081733
2 EXHIBIT 31.1 ex311q22017.htm EX-31.1 17200
3 EXHIBIT 31.2 ex312q22017.htm EX-31.2 17248
4 EXHIBIT 32 ex32q22017.htm EX-32 19996
11 slide1a32.jpg GRAPHIC 336394
12 slide2a27.jpg GRAPHIC 307169
13 slide3a26.jpg GRAPHIC 220543
  Complete submission text file 0001159036-17-000038.txt   6501622

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT halo-20170630.xml EX-101.INS 1075876
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT halo-20170630.xsd EX-101.SCH 42714
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT halo-20170630_cal.xml EX-101.CAL 68040
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT halo-20170630_def.xml EX-101.DEF 162184
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT halo-20170630_lab.xml EX-101.LAB 533334
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT halo-20170630_pre.xml EX-101.PRE 290340
Mailing Address 11388 SORRENTO VALLEY ROAD SAN DIEGO CA 92121-1345
Business Address 11388 SORRENTO VALLEY ROAD SAN DIEGO CA 92121-1345 (858) 794-8889
HALOZYME THERAPEUTICS INC (Filer) CIK: 0001159036 (see all company filings)

IRS No.: 880488686 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32335 | Film No.: 171014873
SIC: 2836 Biological Products, (No Diagnostic Substances)